21.85 (1.35%) Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sun Pharmaceutical Industries has informed that it enclosed the schedule of Analyst/ Institutional Investor Meeting with the Company to be held on 12th August 2021.
The above information is a part of company’s filings submitted to BSE.